Celldex Therapeutics (CLDX) Interest Expenses (2010 - 2026)
Celldex Therapeutics' (CLDX) quarterly Interest Expenses came in at $364000.0 in Q1 2026, up 120.61% year-on-year from $165000.0 in Q1 2025, and up 9000.0% quarter-over-quarter from $4000.0 in Q4 2025.
Celldex Therapeutics (CLDX) Interest Expenses (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Interest Expenses history runs 16 years deep, the most recent figure standing at $364000.0 for Q1 2026.
- On a quarterly basis, Interest Expenses rose 120.61% year-over-year to $364000.0 in Q1 2026; TTM through Mar 2026 was $364000.0, a 120.61% increase from a year earlier, with the FY2025 full-year figure at $374.5 million, up 17.12% from the prior year.
- Interest Expenses rose to $364000.0 in Q1 2026 per CLDX's latest filing, from $4000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $347.4 million in Q4 2023 and bottomed at $3000.0 in Q3 2025.
- The 5-year median for Interest Expenses is $532000.0 (2023), against an average of $58.3 million.
- Across the five-year window, Interest Expenses jumped 4198.41% in 2022 and sank 100.0% in 2025, its largest moves.
- Year by year, Interest Expenses stood at $312.8 million in 2022, then advanced by 11.07% to $347.4 million in 2023, then declined by 7.95% to $319.8 million in 2024, then sank by 100.0% to $4000.0 in 2025, then jumped by 9000.0% to $364000.0 in 2026.
- Per Business Quant, the three latest CLDX Interest Expenses figures stand at $364000.0 (Q1 2026), $4000.0 (Q4 2025), and $3000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Celldex Therapeutics | 2.34 Bn | 2.34 Bn | -1.44 Mn | 364,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 364,000.00 |
| Mar 31, 2026 | 364,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 118,000.00 |
| Jun 30, 2025 | 118,000.00 |
| Mar 31, 2025 | 165,000.00 |
| Mar 31, 2025 | 165,000.00 |
| Dec 31, 2024 | 319.76 Mn |
| Dec 31, 2024 | 319.76 Mn |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 953,000.00 |
| Jun 30, 2024 | 953,000.00 |
| Mar 31, 2024 | 572,000.00 |
| Mar 31, 2024 | 572,000.00 |
| Dec 31, 2023 | 347.39 Mn |
| Dec 31, 2023 | 347.39 Mn |